Blog

  • Greencoat UK Wind Publishes 2025 ESG Report

    Greencoat UK Wind Publishes 2025 ESG Report

    Greencoat UK Wind PLC (LSE:UKW) has released its 2025 Environmental, Social and Governance (ESG) Report, making the document available to investors and stakeholders via its website. The publication highlights the company’s continued focus on transparency and accountability across sustainability metrics, reinforcing its position within the UK renewable infrastructure sector and enabling stakeholders to better evaluate its ESG performance.

    The company’s outlook remains pressured by weaker recent profitability and earnings volatility, including losses and an absence of free cash flow in 2025. Technical indicators also point to a softer trend, with the shares trading below longer-term moving averages and showing negative momentum signals. However, these challenges are partly offset by valuation support from a high dividend yield, alongside moderate leverage and positive operating cash flow.

    More about Greencoat UK Wind

    Greencoat UK Wind PLC is a London-listed investment fund specialising in UK wind farm assets. It offers investors exposure to both onshore and offshore wind generation, with a strategy focused on delivering stable, inflation-linked returns through long-term renewable energy infrastructure investments.

  • GCP Infrastructure Maintains Dividend Target and Sees Limited Impact from UK Energy Policy Changes

    GCP Infrastructure Maintains Dividend Target and Sees Limited Impact from UK Energy Policy Changes

    GCP Infrastructure Investments Limited (LSE:GCP) reaffirmed its income strategy as it declared a quarterly dividend of 1.75 pence per ordinary share for the period from 1 January to 31 March 2026. This keeps the company on track to meet its full-year dividend target of 7.00 pence per share, offering continued income visibility for investors. The FTSE 250-listed fund focuses on UK infrastructure debt assets with long-term, public sector-backed revenue streams and inflation-linked characteristics.

    Management also indicated that recent UK policy developments—including changes to carbon pricing, the electricity generator levy, and proposed wholesale contracts-for-difference—are not expected to have a material impact on portfolio valuations in the near term. The company continues to monitor potential upside opportunities arising from future policy adjustments.

    GCP Infra’s outlook is supported by a conservative balance sheet and improving cash generation, alongside constructive technical trends. However, these strengths are partially offset by uneven or declining revenue trends and a relatively high valuation multiple, despite the appeal of its dividend yield. Ongoing corporate actions, including stable dividend payments and share buybacks, provide additional support.

    More about GCP Infrastructure Investments Limited

    GCP Infrastructure Investments Limited is a London-listed, closed-ended investment company and a constituent of the FTSE 250 index. It invests primarily in UK infrastructure debt and related assets, focusing on projects with long-term, availability-based revenue streams often backed by the public sector. The portfolio is designed to deliver stable returns with partial inflation protection while supporting environmentally beneficial infrastructure.

  • Power Metal Advances Tati Gold Project as Tuscan-Funded Drilling Nears

    Power Metal Advances Tati Gold Project as Tuscan-Funded Drilling Nears

    Power Metal Resources plc (LSE:POW) has progressed its wholly owned Tati Gold Project in Botswana, targeting mineralisation along the Tati Greenstone Belt near Francistown. The company continues to benefit from strong gold market conditions as it advances a portfolio strategy focused on developing assets through partnerships, joint ventures, and potential disposals or spin-outs.

    At Tati, key milestones have been achieved, including environmental approval and the signing of an access agreement covering areas such as Cherished Hope, clearing the way for field activities to commence. Under the agreement, Tuscan Holding will fully fund and operate a structured exploration programme, which includes reverse air blast (RAB) drilling and drone-based surveys. Power Metal will retain a carried 25% interest in the main licence while maintaining full ownership of its remaining Tati licences.

    The upcoming exploration phase will involve approximately 600 metres of RAB drilling, aimed at improving understanding of the geometry and continuity of gold mineralisation at depth. The results are expected to support early mine planning and metallurgical testing. If successful, the partners may pursue permits for a small-scale mining operation of around 50 tonnes per day, offering a potential route to initial production and future cash flow exposure without requiring additional capital investment from Power Metal.

    The company’s outlook reflects a combination of strong revenue growth and a solid balance sheet, though this is offset by operational challenges and continued negative cash flow. While valuation appears attractive, technical indicators suggest caution due to ongoing bearish trends.

    More about Power Metal Resources Plc

    Power Metal Resources plc is a London-listed exploration and project incubation company focused on identifying and developing large-scale opportunities in precious, base, and strategic metals. Its portfolio spans North America, Africa, the Middle East, and Australia, ranging from early-stage exploration assets to more advanced drilling projects. The company aims to unlock value through partnerships, joint ventures, and eventual asset sales or spin-outs to generate returns for shareholders.

  • Bango Grows Recurring Revenue and Profitability as Subscriptions Platform Expands

    Bango Grows Recurring Revenue and Profitability as Subscriptions Platform Expands

    Bango plc (LSE:BGO) reported full-year 2025 revenue of $52.2 million, a 2% decline driven by weaker performance in its Payments division, which was offset by strong growth in its Subscriptions segment. Subscriptions revenue rose 22%, while annual recurring revenue increased 30% to $18.2 million. Adjusted EBITDA improved 7% to $16.4 million, and cash EBITDA turned positive at $2.3 million, supported by higher gross margins of 84%, cost-saving measures including workforce reductions, and lower R&D capital expenditure. Net debt, however, increased to $9.2 million.

    The company’s Digital Vending Machine platform continued to gain momentum, securing 12 new enterprise customers to bring the total to 39. Active subscriptions climbed nearly 60% to 24 million, with adoption now spanning seven of the top eight U.S. telecom operators, alongside new clients across Asia, Turkey, South Africa, and European banking sectors. Bango is also moving away from lower-margin legacy payment routes to improve earnings quality and has strengthened its financial position through new debt facilities.

    Entering 2026, the group reported double-digit growth in both revenue and EBITDA for the first quarter and is targeting positive cash EBITDA from its Subscriptions business by 2027. However, management cautioned that geopolitical uncertainty could slow sales cycles in the near term.

    Bango’s outlook is supported by solid operational performance and continued expansion of its Digital Vending Machine platform, though technical indicators suggest some bearish momentum. Valuation remains a concern due to ongoing earnings pressures and the absence of dividend income. While strategic progress and improved financial flexibility are positive, sustained profitability gains will be key to strengthening investor confidence.

    More about Bango plc

    Bango plc is a UK-based technology company focused on enabling digital content monetisation through global partnerships and payment solutions. Originally a pioneer in carrier billing, the company now centres its strategy on the Digital Vending Machine platform, which facilitates subscription bundling for major brands and telecom operators worldwide.

  • ECR Minerals Progresses Paleogold Acquisition and Expands Australian Gold Portfolio

    ECR Minerals Progresses Paleogold Acquisition and Expands Australian Gold Portfolio

    ECR Minerals plc (LSE:ECR) reported significant progress on its proposed acquisition of Paleogold, with shareholder acceptances now exceeding 94%. The transaction is expected to reshape the company into a multi-asset gold operator spanning 10 projects across several Australian states. The deal would introduce a mix of hard rock and shallow open-pit assets, including Maddens and Salt Bush, alongside an experienced operational team, strengthening ECR’s production pipeline and geographic diversification.

    On the operational front, underground development is advancing at the Maddens Flat Group of Mines, where initial gold production is anticipated in the near term. Following completion of the transaction, ECR is expected to hold a 50% interest in the project. At Raglan, alluvial operations are scaling up after optimisation work, with the site positioned as a near-term cash generator to support corporate overheads and fund development at the larger Blue Mountain project.

    Blue Mountain is moving toward a mining lease after earlier drilling and trial processing activities, with plans to develop it as a follow-on production asset leveraging shared infrastructure with Raglan. Elsewhere, exploration is progressing at Lolworth in Queensland, where a gold-silver system has been identified, while permitting adjustments are underway at Kondaparinga to address native title considerations.

    In South Australia, the Salt Bush project—where ECR will hold a 20% interest post-acquisition—is being advanced as a shallow open-cut opportunity with potential to deliver over 10,000 ounces of gold at relatively low cost. Early work will focus on approvals, infrastructure planning, and processing design to move the asset closer to production.

    Across Victoria, the company is continuing discussions on a potential joint venture with Bold Gold at Creswick, while further exploration is planned at Bailieston, particularly around the Hard Up Reef target. Newly secured ground at Tambo South is set for initial sampling and LIDAR surveys. In Western Australia, Paleogold’s 80% stake in the Tuckanarra project—located near an established resource—will be advanced through new exploration aimed at extending known mineralisation.

    Taken together, the enlarged portfolio would provide ECR with a combination of near-term production assets and exploration opportunities, offering leverage to strong gold prices within a Tier-1 mining jurisdiction. The strategy marks a transition toward a more diversified, multi-project gold company with improved potential for cash generation and a broader investment appeal.

    The company’s outlook remains constrained by weak financial fundamentals, including a lack of revenue, ongoing losses, and continued cash burn. However, a debt-free balance sheet and some improvement in losses provide partial support. Technical indicators are mixed to weak, with negative momentum and the share price below short-term averages, while valuation remains limited by the absence of profitability and dividends.

    More about ECR Minerals

    ECR Minerals plc is a London-listed exploration and development company focused on gold assets across Australia. Its portfolio includes both alluvial and hard rock projects in Queensland, Victoria, South Australia, and Western Australia, with a growing emphasis on near-term production alongside district-scale exploration potential.

  • Shield Therapeutics Begins Japanese Phase II Trial of ACCRUFeR in PAH

    Shield Therapeutics Begins Japanese Phase II Trial of ACCRUFeR in PAH

    Shield Therapeutics plc (LSE:STX) announced that its partner MEDLEAP Pharma has enrolled the first patient in a Phase II clinical trial in Japan assessing ACCRUFeR (ferric maltol) for the treatment of pulmonary arterial hypertension (PAH). The exploratory study has been supported by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and builds on previous clinical work conducted in Europe, the UK, and the United States, with the aim of progressing toward a Phase III programme.

    The trial marks an expansion of ferric maltol beyond its established use in iron deficiency into the Japanese PAH market, estimated at over US$230 million. Iron supplementation is already widely recommended for eligible PAH patients, and successful clinical development could extend Shield’s therapeutic reach, deepen its collaboration with MEDLEAP, and create a new commercial opportunity in a specialised cardiovascular segment.

    The company’s outlook remains constrained by weak financial fundamentals, including continued losses, negative operating and free cash flow, and a negative equity position. However, improving revenue trends and margins, along with moderately positive share price momentum, offer some support. Valuation remains challenged due to the absence of profitability and dividend income.

    More about Shield Therapeutics

    Shield Therapeutics is a commercial-stage pharmaceutical company specialising in treatments for iron deficiency, with or without anaemia. Its lead product, ACCRUFeR (also marketed as FeRACCRU), is an oral iron therapy approved in the United States and commercialised across Europe, Canada, and other regions through partnerships. The product is protected by patents extending into the mid-2030s and targets a global market for iron deficiency and anaemia estimated at around US$2.3 billion.

  • One Health Group Surpasses FY26 Expectations and Progresses First Surgical Hub

    One Health Group Surpasses FY26 Expectations and Progresses First Surgical Hub

    One Health Group PLC (LSE:OHGR) delivered a strong performance for the year ended 31 March 2026, exceeding market expectations in its first full year on AIM. Revenue increased 13% to £32 million, while NHS patient referrals rose 11% and surgical procedures grew 15%. The company also reported improvements across key operational metrics, including higher consultation volumes, an expanded consultant base, additional outreach clinics, and increased surgical capacity. With cash reserves of £11.1 million, the group remains well positioned to fund further expansion.

    The company also confirmed that construction has begun on its first dedicated surgical hub in Scunthorpe. The project remains on track within its £8 million to £9 million budget and is expected to support faster growth and enhanced profitability once operational. Management continues to focus on organic expansion, driven by rising patient referrals, a strong pipeline of surgeons, and increased surgical capacity. This strategy reinforces One Health’s role in addressing NHS waiting list pressures, particularly in under-served regions with high demand for care.

    More about One Health Group PLC

    One Health Group PLC is an independent provider of NHS-funded surgical services, operating through a network of 14 hospitals and 40 community-based outreach clinics across regions including Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire, and Leicestershire. The company specialises in areas such as orthopaedics, spine, general surgery, gynaecology, and urology, treating patients referred through the NHS Patient Choice framework and partnerships with integrated care boards and local NHS trusts.

    It works with 88 NHS consultants and a wider team of more than 140 professionals to deliver consultations, surgical procedures, and follow-up physiotherapy closer to patients’ homes. The group is positioned to benefit from long-term demand drivers in areas such as orthopaedics and spinal care, supported by demographic trends including an ageing population and rising obesity levels.

  • CLS Holdings Agrees €60 Million Sale of Refurbished Essen Office Asset

    CLS Holdings Agrees €60 Million Sale of Refurbished Essen Office Asset

    CLS Holdings plc (LSE:CLI) has agreed the unconditional disposal of The Brix, a 21,797 square metre office property in central Essen, Germany, for €60 million—aligned with its year-end 2025 valuation. The transaction is expected to complete in the second quarter of 2026. Situated بالقرب of Essen’s main railway station, the asset benefits from strong connectivity across the wider Ruhr region.

    CLS originally acquired the building in April 2021 when it had a vacancy rate of 28% and subsequently undertook a major repositioning. Following an extensive refurbishment and the securing of a new 30-year lease with the City of Essen, The Brix has been transformed into a modern, sustainable office asset delivering stable long-term income. The proceeds from the sale will be directed toward debt reduction, with management noting that the transaction realises value created, refines the group’s German portfolio focus, and highlights its active asset management approach.

    The company’s outlook remains pressured by ongoing profitability challenges and relatively high leverage for an office-focused REIT. Technical indicators are also weak, with the share price trading below key moving averages and showing negative momentum. While a high dividend yield and generally solid cash flow offer some support, they do not fully offset concerns around earnings performance and market trends.

    More about CLS Holdings

    CLS Holdings plc is a London-based property investment group specialising in office assets across the UK and continental Europe, particularly Germany. The company focuses on acquiring, refurbishing, and repositioning properties to secure long-term leases with public-sector and blue-chip tenants, aiming to deliver устойчивый rental income from high-quality, sustainable office space.

  • Seraphim Space Investment Trust Launches Retail Offer of C Shares

    Seraphim Space Investment Trust Launches Retail Offer of C Shares

    Seraphim Space Investment Trust (LSE:SSIT) has introduced a conditional retail offering of new C Shares priced at £1.00 each via the RetailBook platform, running alongside an institutional placing. The offer is open to eligible UK investors with a minimum subscription of £250 and can be accessed through ISAs, SIPPs, and general investment accounts. It is scheduled to close on 6 May 2026, pending shareholder approval and the admission of the new shares to trading on the London Stock Exchange.

    Funds raised will be allocated to a separate pool through the C Share structure, with conversion into ordinary shares taking place over time based on capital deployment and quarterly net asset value calculations. This approach allows incoming investors to gain exposure to the portfolio while limiting dilution risk for existing shareholders, particularly from undeployed cash. The structure supports the trust’s strategy of scaling its SpaceTech portfolio through a pipeline of new investment opportunities.

    The company’s outlook is constrained by inconsistent cash flow quality and earnings that are heavily influenced by valuation swings, despite maintaining a strong debt-free balance sheet. Market technicals indicate positive momentum and an established uptrend, though valuation metrics remain less supportive given the lack of a clear price-to-earnings signal and no stated dividend yield.

    More about Seraphim Space Investment Trust Plc

    Seraphim Space Investment Trust plc is a London-listed closed-ended fund focused on the SpaceTech sector. It invests in a broad portfolio of high-growth companies involved in satellite technology, data infrastructure, and space-enabled services, leveraging a global network to identify and support early- and growth-stage businesses in the space economy.

  • Yellow Cake Grows Uranium Holdings and NAV Amid Strong Market Conditions

    Yellow Cake Grows Uranium Holdings and NAV Amid Strong Market Conditions

    Yellow Cake plc (LSE:YCA) reported a solid first quarter to 31 March 2026, supported by rising—though volatile—uranium prices and additional acquisitions that increased the value of its physical holdings. The company expanded its inventory from 21.68 million pounds to 23.11 million pounds of U3O8, primarily through deliveries under its long-term agreement with Kazatomprom as well as selective spot market purchases. All material continues to be stored at facilities operated by Cameco and Orano.

    An oversubscribed equity placing raised approximately £80.6 million, allowing Yellow Cake to commit US$100 million toward further uranium purchases from Kazatomprom. These additional deliveries are expected to increase total holdings to around 24.37 million pounds later in the year. Over the quarter, the value of its uranium portfolio climbed 9.7% to US$1.94 billion, contributing to a 5% rise in estimated net asset value per share and reinforcing its exposure to tightening supply dynamics and increasing global demand for nuclear energy.

    Despite its strong asset backing and a debt-free balance sheet, the company’s outlook is tempered by inconsistent financial performance, including ongoing negative cash flow and earnings volatility. Technical indicators remain supportive, with the shares in an upward trend, although near-overbought conditions and a negative price-to-earnings ratio limit the overall investment case.

    More about Yellow Cake plc

    Yellow Cake plc is a specialist investment vehicle focused on the uranium market. Rather than operating mines, the company holds physical U3O8 for the long term and engages in uranium-related commercial activities. Its holdings are stored in Canada and France, offering investors direct exposure to uranium price movements within a market shaped by constrained supply and growing nuclear energy demand.